Sama CEO Wendy Gonzalez to Speak at CogX Leadership Summit on AI
3.10.2024 03:00:00 EEST | ACCESS Newswire | Press release
Gonzalez to discuss how to deploy responsible AI across an organization, and the importance of diverse leadership in fostering AI innovation and improving bottom line performance
LONDON, UNITED KINGDOM / ACCESSWIRE / October 3, 2024 / Sama, the leader in purpose-built, responsible enterprise AI with agile data labeling for model development and supervised fine-tuning, today announced that CEO Wendy Gonzalez will speak in two separate sessions at the upcoming CogX Leadership Summit on AI, taking place in London on October 7, 2024.
In her first session of the conference, slated for 12 noon in the Prince of Wales room, Gonzalez will join Gopal Ramchurn of Responsible AI UK and Nia Castelly, co-founder and head of legal at Checks, Google's AI-powered platform that helps developers build safer products by simplifying privacy compliance. Entitled Demystifying Responsible AI: A Guide for Leaders, this panel will explore the challenges, opportunities, regulatory considerations and strategies necessary to successfully deploy responsible AI.
Gonzalez will also participate in a panel discussion entitled AI Leadership: Unlocking Innovation through Diverse Voices, taking place at 2 pm in the Prince of Wales room. This session will include Sana Wajid, chief development officer at Fetch AI; Christian Tooley, senior manager, EMEA at Bain Capital; and Katie Lockwood, co-founding partner of Twin Path Ventures. The discussion, which will cover the critical need for diverse leadership in fostering AI-driven innovation, and its impact on market competitiveness and financial performance, will be moderated by Rula Awad, machine learning engineer at Women in AI.
"We are in such an exciting period of time, at the precipice of significant global changes thanks to the power and potential of AI. However, without a conscientious effort to ensure ethical and responsible AI practices that prioritize a diverse group of voices, we could be facing a future rife with problems," said Gonzalez. "CogX always brings together a wide range of experts who are at the forefront of creating the best possible future for AI. I'm thrilled to be a part of these important conversations to move the industry forward on the best path possible."
A certified B corp, Sama is committed to leading the industry in responsible AI, prioritizing compliance with critical AI legislation around the world. The company's impact mission has resulted in lifting over 68,000 individuals out of poverty, and its most recent Impact Report details significant strides toward its sustainability goals, including efforts to become net zero by 2050 and its role in the United Nations Global Compact (UNGC), the world's largest voluntary corporate sustainability initiative.
CogX Festival is a global event focused on the impact of artificial intelligence and emerging technology on industry, government and society. This year's conference will focus on the crucial question, "How to seize the AI opportunity?" Tickets are available with a 25% discount via https://www.cogxleadershipsummit.com/tickets.
About Sama
Sama is a global leader in data annotation solutions for computer vision, generative AI and large language models. Our solutions minimize the risk of model failure and lower the total cost of ownership through an enterprise ready ML-powered platform and SamaIQ™, actionable data insights uncovered by proprietary algorithms and a highly skilled on-staff team of over 5,000 data experts. 40% of FAANG companies and other major Fortune 50 enterprises, including GM, Ford and Microsoft, trust Sama to help deliver industry-leading ML models.
Driven by a mission to expand opportunities for underserved individuals through the digital economy, Sama is a certified B-Corp and has helped more than 68,000 people lift themselves out of poverty. An MIT-led Randomized Controlled Trial has validated its training and employment program. For more information, visit www.sama.com.
Sama Media Contact:
press@samasource.org
SOURCE: Sama
View the original press release on accesswire.com
Sama

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 16:45:00 EET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 16:00:00 EET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 15:00:00 EET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 15:00:00 EET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
Formerra and Evonik Expand Distribution Partnership for Healthcare Grades2.2.2026 16:00:00 EET | Press release
Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada ROMEOVILLE, ILLINOIS / ACCESS Newswire / February 2, 2026 / Formerra, a leader in performance materials distribution, today announced an expanded distribution agreement that brings Evonik's CARE brand healthcare grades into Formerra's medical portfolio. Covering the United States and Canada, the agreement creates new access points for high-performance polyamides used in essential healthcare applications. This expansion kicks off at MD&M West 2026 this week, and underscores both companies' commitment to supporting the healthcare market with high-performance materials, responsive service, and continuity of supply. It also builds on the companies' two-year partnership, which introduced Evonik's VESTAMID® and TROGAMID® families to Formerra's engineered materials lineup. With this expansion, Formerra will support Evonik healthcare grades designed for fluid handling, drug delivery, diagnostic systems, surgi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom